We screened LRRK2 mutations in exon 41 in 904 parkin-negative Parkinson's disease (PD) patients (868 probands) from 18 countries across 5 continents. We found three heterozygous missense (novel I2012T, G2019S, and I2020T) mutations in LRRK2 exon 41. We identified 11 (1.3%) among 868 PD probands, inc
Neurodegenerative disease: microRNAs under threat from LRRK2
β Scribed by Wiedemann, Claudia
- Book ID
- 109963135
- Publisher
- Nature Publishing Group
- Year
- 2010
- Tongue
- English
- Weight
- 167 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1471-0048
- DOI
- 10.1038/nrn2906
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The __LRRK2__ gene is a key player in Parkinson's disease (PD), however prevalence and pathogenicity of __LRRK2__ variants remain to be investigated in ethnically diverse populations. Herein, we performed comprehensive sequencing of the __LRRK2__ gene in 92 Tunisian probands with famili
## Abstract Mutations in __LRRK2__, the gene that encodes leucineβrich repeat kinase 2 (LRRK2), are associated with autosomal dominant and sporadic forms of Parkinson's disease (PD) and are the most common genetic causes of PD. Recently, a R1628P variant has been reported as a risk factor for PD in